An additional reason for Dr Smith's resignation might be that perhaps he feels a little conflicted seeing as he is CMO and on the board of Cardiol which is developing a cannabinoid based nanotherapeutic for heart failure and now heart failure is looming larger for RVX. I didn't see anything on the Zenith site saying that he is resigning his Zenith seat. I guess we will see soon enough if he stays on there.